Skip to content

COVID-19 Simulation Education on Nursing Students

The Effect of Simulation Education as an Approach to Patients With COVID-19 on Nursing Students' Perception and Fear of COVID-19 Disease: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05576636
Enrollment
86
Registered
2022-10-12
Start date
2021-11-10
Completion date
2022-09-10
Last updated
2023-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Pandemic, Simulation of Physical Illness

Keywords

nursing student, perception of illness, fear of death.

Brief summary

This study aims to determine the effect of simulation education as an approach to patients with COVID-19 on nursing students' perception and fear of the COVID-19 disease. This study was conducted in a randomized controlled trials with 86 nursing students from a university between November 10 and December 10, 2021.

Interventions

BEHAVIORALSimulation training

Expectations regarding the scenario were explained to the participants before the implementation. They were given information about the standard patient. Roles were distributed, and the implementation time of the scenario was announced. Written permission was obtained from students involved in the scenario. The intervention group was given scenario-based education appropriate for the approach to a standard patient with COVID-19. During the implementation of the scenario, the instructor did not interfere with students, and after the feedback, the show-do method was used to improve the incorrect skill steps. Two instructors evaluated students' performance on the standard patient simulation as achieved-failed and the application was recorded as a pre-test.

OTHERControl Group

The control group didn't apply any interference during the study. Participants in the control group continued their routine follow-up.

Sponsors

Mehmet Akif Ersoy University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

They did not know if they were in the control and intervention group at the time of randomization.

Eligibility

Sex/Gender
ALL
Age
No minimum to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Nursing student and * Agreeing to participate in the study

Exclusion criteria

* Refusing to participate in the study or quitting the study

Design outcomes

Primary

MeasureTime frameDescription
Approach to COVID-19 Patient Form5 MinuteThis form was created by the researchers following a review of the literature (Collado-Boira et al., 2020; Cervera-Gasch, Gonz ́alez-Chorda ́, & Mena-Tudela, 2020; Kurt, & Dalkıran, 2021; Ulenaers, et al., 2021; Işık, Konuş, & Bakar, 2021) and was evaluated by 3 experts who had a PhD degree in the field, and necessary improvements were made in line with their suggestions. It consists of 14 items in total. This form includes interventions, such as The mask should be worn before entering the patient room or care area and Disposable respiratory and face masks should be removed and discarded after leaving the patient's room or care area and closing the door. The correct application of these interventions was scored with 1 point and the incorrect application with 0 points. Scores range between 0 and 14. As the scores increase, the accuracy level of the approach to the patient increases, as well.
The Fear of COVID-19 Scale5 MinuteThis scale was developed by Ahorsu et al. (2022), and its Turkish adaptation, validity, and reliability studies were performed by Ladikli et al. (2020). The scale has a single factor structure and consists of seven 5-point Likert-type (1 = strongly disagree; 5 = strongly agree) items. Scores on the scale range between 7 and 35. The higher the score is, the higher the fear of the COVID-19 pandemic is. Cronbach's alpha value of the scale is 0.82 (Ladikli et al., 2020).
The COVID-19 Disease Perception Scale5 MinuteThis scale was developed by Geniş et al. (2020). It consists of seven items. It has a five-point Likert-type structure and consists of two sub-dimensions. The total score is calculated by summing the scores of the items on the sub-dimension and dividing the results by the number of items on that sub-dimension. This operation yields a value between 1 and 5. High scores on the dangerousness sub-dimension indicate that the perceived dangerousness of the disease is high, and high scores on the contagiousness sub-dimension indicate that the perceived contagiousness of the disease is high. Cronbach's alpha value of the original scale is 0.78 (Geniş et al., 2020).

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026